• Identification of potential innovative solutions to the problem.
8:00 a.m. Continental Breakfast Available
8:30 a.m. Opening Remarks
GAIL CASSELL, Workshop Co-Chair
Visiting Professor, Department of Global Health and Social
Medicine, Harvard Medical School
Vice President, TB Drug Discovery, Infectious Disease
Vice President, Scientific Affairs and Distinguished Lilly
Research Scholar for Infectious Diseases, Eli Lilly and Company (retired)
BARRY BLOOM, Workshop Co-Chair
Distinguished Service Professor, Department of Immunology and Infectious Diseases, Harvard University
Dean of the Harvard School of Public Health (former)
SESSION I: OVERVIEW OF THE BARRIERS IN THE SUPPLY CHAIN FOR MDR TB DRUGS
• Provide an overview of the history and current operational structure of the supply chain for SLDs for MDR TB.
• Examine barriers preventing the optimal operation of the current supply chain.
• Discuss implications for access to SLDs as they are approved and become available as new drugs on the market.
9:00 a.m. Overview, Background, and Session Objectives
PETER CEGIELSKI, Session Chair
Team Leader for Drug-Resistant TB
International Research and Programs Branch, Division of Tuberculosis Elimination
U.S. Centers for Disease Control and Prevention